dc.contributor.author | Mesut, Burcu | |
dc.contributor.author | Kazaz, Çağla | |
dc.contributor.author | Özsoy, Yıldız | |
dc.contributor.author | Ocak, Emine Meltem | |
dc.date.accessioned | 2021-12-10T13:03:06Z | |
dc.date.available | 2021-12-10T13:03:06Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Kazaz Ç., Mesut B., Özsoy Y., Ocak E. M. , "Formulation development and evaluation of taste-masked atomoxetine hydrochloride orally disintegrating tablets (Odts)", Journal of Research in Pharmacy, cilt.25, sa.5, ss.715-727, 2021 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_eaaccbaf-0f49-493b-ad64-b2a6a7fd6847 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/175296 | |
dc.identifier.uri | https://doi.org/10.29228/jrp.62 | |
dc.description.abstract | © 2021 Marmara University Press ISSN: 2630-6344.Atomoxetine hydrochloride is a selective norepinephrine reuptake inhibitor used for the treatment of attention deficit/hyperactivity disorder. Atomoxetine hydrochloride is available in the form of capsules and oral solutions, yet it has no orally disintegrating form due to its bitter taste. ODTs are formulated to disintegrate rapidly upon contact with saliva and enable oral administration without water or chewing and offer improved patient compliance and ease of administration. Appropriate taste masking has great importance for ODTs. In this study, developing a taste-masked ODT formulation containing atomoxetine hydrochloride produced using the wet granulation method was aimed. Formulations were designed by changing the granulation agent (Hydroxypropylmethylcellulose (HPMC), Gellan gum, Veegum, Polyethylene glycol (PEG) 20000P) and active substance to granulation agent ratio (1:2, 1:3, 1:4). Each formulation was tested physically and chemically. According to the results, it was concluded that Gellan gum is more appropriate for use in ODTs for taste masking. | |
dc.language.iso | eng | |
dc.subject | Drug Guides | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Life Sciences | |
dc.subject | Health Sciences | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | Multidisciplinary | |
dc.subject | Pharmacology | |
dc.subject | General Pharmacology, Toxicology and Pharmaceutics | |
dc.subject | Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | |
dc.subject | Pharmacology (medical) | |
dc.subject | Pharmacy | |
dc.subject | Temel Bilimler (SCI) | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Doğa Bilimleri Genel | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | ÇOK DİSİPLİNLİ BİLİMLER | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Eczacılık | |
dc.title | Formulation development and evaluation of taste-masked atomoxetine hydrochloride orally disintegrating tablets (Odts) | |
dc.type | Makale | |
dc.relation.journal | Journal of Research in Pharmacy | |
dc.contributor.department | Ali Raif Pharmaceutical Corporation , , | |
dc.identifier.volume | 25 | |
dc.identifier.issue | 5 | |
dc.identifier.startpage | 715 | |
dc.identifier.endpage | 727 | |
dc.contributor.firstauthorID | 2741025 | |